• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets - Product Image

The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets

  • ID: 1235118
  • May 2010
  • 138 Pages
  • GBI Research

FEATURED COMPANIES

  • Alcon, Inc.
  • Allergan, Inc.
  • Merck & Co Inc
  • Novartis AG
  • Pfizer
  • Roche
  • MORE

“The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 – Strategies to Counter Generic Erosion in Key Markets", provides in-depth analysis of the unmet needs, drivers and barriers that impact the global ophthalmology therapeutics market. The report analyzes the ophthalmology markets in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes:

- Annualized market data for the ophthalmology market from 2001 to 2009, forecast forward to 2016.

- Analysis of the leading therapeutic segments, including glaucoma, macular degeneration, macular edema READ MORE >

FEATURED COMPANIES

  • Alcon, Inc.
  • Allergan, Inc.
  • Merck & Co Inc
  • Novartis AG
  • Pfizer
  • Roche
  • MORE

1 TOC
1.1 List of Tables
1.2 List of Figures

2 Global Ophthalmology Therapeutics Market: Introduction
2.1 GBI Research Report Guidance

3 Global Ophthalmology Therapeutics Market: Market Overview
3.1 Introduction
3.2 Revenue Forecasts for the Global Ophthalmology Therapeutics Market
3.2.1 Sales Value
3.2.2 Annual Cost of Therapy
3.2.3 Treatment Usage Patterns
3.2.4 Generics’ Share in the Global Ophthalmology Therapeutics Market
3.2.5 Sales of Leading Drugs

4 Global Ophthalmology Therapeutics Market: Therapeutic Landscape
4.1 Glaucoma Market
4.1.1 Introduction
4.1.2 Unmet Needs
4.1.3 Sales Value
4.1.4 Sales Volume
4.1.5 Annual Cost of Therapy
4.1.6 Treatment Usage Patterns
4.1.7 Geographical Segmentation
4.1.8 Drivers of the Glaucoma Market
4.1.9 Restraints for Glaucoma Market
4.2 Macular Edema
4.2.1 Introduction
4.2.2 Unmet Needs
4.2.3 Sales Value
4.2.4 Sales Volume
4.2.5 Annual Cost of Therapy
4.2.6 Treatment Usage Patterns
4.2.7 Geographical Segmentation
4.2.8 Drivers of the Macular Edema Market
4.2.9 Restraints For Macular Edema Market
4.3 Macular Degeneration Market
4.3.1 Introduction
4.3.2 Unmet Needs
4.3.3 Sales Value
4.3.4 Sales Volume
4.3.5 Annual Cost of Therapy
4.3.6 Treatment Usage Patterns
4.3.7 Geographical Segmentation
4.3.8 Drivers of Macular Degeneration Market
4.3.9 Restraints for Macular Degeneration Market
4.4 Allergic Conjunctivitis Market
4.4.1 Introduction
4.4.2 Unmet Needs
4.4.3 Sales Value
4.4.4 Sales Volume
4.4.5 Annual Cost of Therapy
4.4.6 Treatment Usage Patterns
4.4.7 Geographical Segmentation
4.4.8 Drivers of Allergic Conjunctivitis Market
4.4.9 Restraints for Allergic Conjunctivitis Market

5 Global Ophthalmology Therapeutics Market: Geographical Landscape
5.1 Geographical Break-up
5.2 The US
5.2.1 Sales Value
5.2.2 Annual Cost of Therapy
5.2.3 Treatment Usage Patterns
5.3 Top Five Countries in Europe
5.3.1 Sales Value
5.3.2 Annual Cost of Therapy
5.3.3 Treatment Usage Patterns
5.4 Japan
5.4.1 Sales Value
5.4.2 Annual Cost of Therapy
5.4.3 Treatment Usage Patterns

6 Global Ophthalmology Therapeutics Market: Pipeline Analysis
6.1 Introduction
6.2 Research and Development Pipeline by Phase
6.2.1 Research and Development Pipeline – Macular Degeneration
6.2.2 Research and Development Pipeline – Glaucoma
6.2.3 Research and Development Pipeline – Macular Edema
6.2.4 Research and Development Pipeline – Allergic Conjunctivitis
6.3 R&D Trends
6.3.1 New Promising Treatments for Diabetic Retinopathy
6.3.2 Combination Drugs Will be a Key Component of Ophthalmology Research and Development
6.4 Profiles of Key Drugs in the Glaucoma Pipeline
6.4.1 Saflutan (tafluprost)
6.4.2 NCX-116 (Formerly PF-03187207)
6.4.3 Catioprost
6.5 Profiles of Key Drugs in Macular Edema and Diabetic Retinopathy Pipeline
6.5.1 Iluvien
6.5.2 iCo-007
6.6 Profiles of Key Drugs in Macular Degeneration Pipeline
6.6.1 ACU-4429
6.6.2 AL-8309
6.7 Profiles of Key Drugs in Allergic Conjunctivitis Pipeline
6.7.1 FOV1101 (Prednisporin)

7 Global Ophthalmology Therapeutics Market: Competitive Landscape
7.1 Market Share Analysis: Ophthalmology
7.2 Competitive Profiling
7.2.1 Pfizer
7.2.2 Allergan, Inc
7.2.3 Alcon, Inc
7.2.4 Novartis AG
7.2.5 Merck & Co Inc
7.2.6 Roche

8 Global Ophthalmology Therapeutics Market: Strategic Consolidations
8.1 Overview
8.1.1 Valeant Pharmaceuticals International Agrees to Acquire Aton Pharma Inc
8.1.2 Healthcare of Today, Inc. has Acquired MacuCLEAR, Inc
8.1.3 Opko Health, Inc. has Acquired Pharmacos Exakta
8.1.4 Sanofi-aventis Acquired Fovea Pharmaceuticals
8.1.5 Alcon, Inc Acquired ESBATech AG
8.1.6 Aton Pharma, Inc. Acquired Marketing Rights to Ophthalmology Drug
8.2 R&D Licensing Agreements
8.2.1 General
8.2.2 Preclinical and Discovery
8.2.3 Phase I
8.2.4 Phase II
8.2.5 Phase III
8.2.6 Approved

9 Global Ophthalmology Therapeutics Market: Appendix
9.1 Market Definitions
9.2 Abbreviations
9.3 Research Methodology
9.3.1 Coverage
9.3.2 Secondary Research
9.3.3 Primary Research
9.3.4 Forecasts
9.3.5 Expert Panel Validation
9.4 Contact Us
9.5 Disclaimer
9.6 Sources

List of Tables:

Table 1: Ophthalmology Therapeutics Market, Global, Key Indications, 2010
Table 2: Ophthalmology Therapeutics Market, Global, Sales Value ($bn), 2001-2009
Table 3: Ophthalmology Therapeutics Market, Global, Sales Value ($bn), 2009-2016
Table 4: Ophthalmology Therapeutics Market, Global, Annual Cost of Therapy ($), 2001-2009
Table 5: Ophthalmology Therapeutics Market, Global, Annual Cost of Therapy ($), 2009-2016
Table 6: Ophthalmology Therapeutics Market, Global, Treatment Usage Patterns, 2001-2009
Table 7: Ophthalmology Therapeutics Market, Global, Treatment Usage Patterns, 2009-2016
Table 8: Ophthalmology Therapeutics Market, Global, Diseased Population (millions), 2001-2009
Table 9: Ophthalmology Therapeutics Market, Global, Diseased Population (millions), 2009-2016
Table 10: Ophthalmology Therapeutics Market, Global, Treatment Seeking Population (millions), 2001-2009
Table 11: Ophthalmology Therapeutics Market, Global, Treatment Seeking Population (millions), 2009-2016
Table 12: Ophthalmology Therapeutics Market, Global, Diagnosed Population (millions), 2001-2009
Table 13: Ophthalmology Therapeutics Market, Global, Diagnosed Population (millions), 2009-2016
Table 14: Ophthalmology Therapeutics Market, Global, Prescription Population (millions), 2001-2009
Table 15: Ophthalmology Therapeutics Market, Global, Prescription Population (millions), 2009-2016
Table 16: Ophthalmology Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($bn), 2001-2009
Table 17: Ophthalmology Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($bn), 2009-2016
Table 18: Ophthalmology Therapeutics Market, Global, Sales of Leading Drugs, 2009
Table 19: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Value ($bn), 2001-2009
Table 20: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Value ($bn), 2009-2016
Table 21: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Volume (Millions), 2001-2009
Table 22: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Volume (Millions), 2009-2016
Table 23: Ophthalmology Therapeutics Market, Global, Glaucoma Annual Cost of Therapy ($), 2001-2009
Table 24: Ophthalmology Therapeutics Market, Global, Glaucoma Annual Cost of Therapy ($), 2009-2016
Table 25: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Usage Patterns, 2001-2009
Table 26: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Usage Patterns, 2009-2016
Table 27: Ophthalmology Therapeutics Market, Global, Glaucoma Diseased Population, 2001-2009
Table 28: Ophthalmology Therapeutics Market, Global, Glaucoma Diseased Population, 2009-2016
Table 29: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Seeking Population, 2001-2009
Table 30: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Seeking Population, 2009-2016
Table 31: Ophthalmology Therapeutics Market, Global, Glaucoma Diagnosed Population, 2001-2009
Table 32: Ophthalmology Therapeutics Market, Global, Glaucoma Diagnosed Population, 2009-2016
Table 33: Ophthalmology Therapeutics Market, Global, Glaucoma Prescription Population, 2001-2009
Table 34: Ophthalmology Therapeutics Market, Global, Glaucoma Prescription Population, 2009-2016
Table 35: Ophthalmology Therapeutics Market, Global, Glaucoma Revenue by Geography, 2001-2009
Table 36: Ophthalmology Therapeutics Market, Global, Glaucoma Revenue by Geography, 2009-2016
Table 37: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Value ($bn), 2001-2009
Table 38: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Value ($bn), 2009-2016
Table 39: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Volume (million), 2001-2009
Table 40: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Volume (million), 2009-2016
Table 41: Ophthalmology Therapeutics Market, Global, Annual Cost of Macular Edema Treatment, 2001-2009
Table 42: Ophthalmology Therapeutics Market, Global, Annual Cost of Macular Edema Treatment, 2009-2016
Table 43: Ophthalmology Therapeutics Market, Global, Macular Edema Treatment Usage Patterns, 2001-2009
Table 44: Ophthalmology Therapeutics Market, Global, Macular Edema Treatment Usage Patterns, 2009-2016
Table 45: Ophthalmology Therapeutics Market, Global, Macular Edema Diseased Population, 2001-2009
Table 46: Ophthalmology Therapeutics Market, Global, Macular Edema Diseased Population, 2009-2016
Table 47: Ophthalmology Therapeutics Market, Global, Macular Edema Diagnosed Population, 2001-2009
Table 48: Ophthalmology Therapeutics Market, Global, Macular Edema Diagnosed Population, 2009-2016
Table 49: Ophthalmology Therapeutics Market, Global, Macular Edema Prescription Population, 2001-2009
Table 50: Ophthalmology Therapeutics Market, Global, Macular Edema Prescription Population, 2009-2016
Table 51: Ophthalmology Therapeutics Market, Global, Macular Edema Revenue by Geography, 2001-2009
Table 52: Ophthalmology Therapeutics Market, Global, Macular Edema Revenue by Geography, 2009-2016
Table 53: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Value ($bn), 2001-2009
Table 54: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Value ($bn), 2009-2016
Table 55: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Volume (Thousands), 2001-2009
Table 56: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Volume (Thousands), 2009-2016
Table 57: Ophthalmology Therapeutics Market, Global, Macular Degeneration Annual Cost of Therapy ($), 2001-2009
Table 58: Ophthalmology Therapeutics Market, Global, Macular Degeneration Annual Cost of Therapy ($), 2009-2016
Table 59: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Usage Patterns, 2001-2009
Table 60: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Usage Patterns, 2009-2016
Table 61: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diseased Population (Thousands), 2001-2009
Table 62: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diseased Population (Thousands), 2009-2016
Table 63: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Seeking Population (Thousands), 2001-2009
Table 64: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Seeking Population (Thousands), 2009-2016
Table 65: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diagnosed Population (Thousands), 2001-2009
Table 66: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diagnosed Population (Thousands), 2009-2016
Table 67: Ophthalmology Therapeutics Market, Global, Macular Degeneration Prescription Population (Thousands), 2001-2009
Table 68: Ophthalmology Therapeutics Market, Global, Macular Degeneration Prescription Population (Thousands), 2009-2016
Table 69: Ophthalmology Therapeutics Market, Global, Macular Degeneration Market, Revenue by Geography ($m), 2001-2009
Table 70: Ophthalmology Therapeutics Market, Global, Macular Degeneration Market, Revenue by Geography ($m), 2009-2016
Table 71: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Value ($m), 2001-2009
Table 72: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Value ($m), 2009-2016
Table 73: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Volume (Millions), 2009-2009
Table 74: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Volume (Millions), 2009-2016
Table 75: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Annual Cost of Therapy ($), 2001-2009
Table 76: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Annual Cost of Therapy ($), 2009-2016
Table 77: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Usage Patterns (Millions), 2001-2009
Table 78: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Usage Patterns (Millions), 2009-2016
Table 79: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diseased Population (Millions), 2001-2009
Table 80: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diseased Population (Millions), 2009-2016
Table 81: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Seeking Population (Millions), 2001-2009
Table 82: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Seeking Population (Millions), 2009-2016
Table 83: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diagnosed Population (Millions), 2009-2009
Table 84: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diagnosed Population (Millions), 2001-2016
Table 85: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Prescription Population (Million), 2001-2009
Table 86: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Prescription Population (Million), 2009-2016
Table 87: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Market, Revenue by Geography ($m), 2001-2009
Table 88: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Market ($m), Revenue by Geography, 2009-2016
Table 89: Ophthalmology Therapeutics Market, Global, Sales Value by Geography ($ bn), 2001-2009
Table 90: Ophthalmology Therapeutics Market, Global, Sales Value by Geography ($ bn), 2009-2016
Table 91: Ophthalmology Therapeutics Market, US, Sales Value ($ bn), 2001-2009
Table 92: Ophthalmology Therapeutics Market, US, Sales Value ($ bn), 2009-2016
Table 93: Ophthalmology Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2009
Table 94: Ophthalmology Therapeutics Market, US, Annual Cost of Therapy ($), 2009-2016
Table 95: Ophthalmology Therapeutics Market, US, Treatment Usage Patterns, 2001-2009
Table 96: Ophthalmology Therapeutics Market, US, Treatment Usage Patterns, 2009-2016
Table 97: Ophthalmology Therapeutics Market, US, Diseased Population (Millions), 2001-2009
Table 98: Ophthalmology Therapeutics Market, US, Diseased Population (Millions), 2009-2016
Table 99: Ophthalmology Therapeutics Market, US, Treatment Seeking Population (Millions), 2001-2009
Table 100: Ophthalmology Therapeutics Market, US, Treatment Seeking Population (Millions), 2009-2016
Table 101: Ophthalmology Therapeutics Market, US, Diagnosed Population (Millions), 2001-2009
Table 102: Ophthalmology Therapeutics Market, US, Diagnosed Population, 2001-2009
Table 103:Ophthalmology Therapeutics Market, US, Prescription Population (Millions), 2001-2009
Table 104: Ophthalmology Therapeutics Market, US, Prescription Population (Millions), 2009-2016
Table 105:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2001-2009
Table 106:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2009-2016
Table 107:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2009
Table 108:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2009-2016
Table 109:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns, 2001-2009
Table 110:Ophthalmology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns, 2009-2016
Table 111:Ophthalmology Therapeutics Market, Japan, Sales Value ($ bn), 2001-2009
Table 112:Ophthalmology Therapeutics Market, Japan, Sales Value ($ bn), 2009-2016
Table 113: Ophthalmology Therapeutics Market, Japan, Annual Cost of Therapy ($), 2001-2009
Table 114:Ophthalmology Therapeutics Market, Japan, Annual Cost of Therapy ($), 2009-2016
Table 115:Ophthalmology Therapeutics Market, Japan, Treatment Usage Patterns, 2001-2009
Table 116:Ophthalmology Therapeutics Market, Japan, Treatment Usage Patterns, 2009-2016
Table 117:Ophthalmology Therapeutics Market, Japan, Diseased Population (Millions), 2001-2009
Table 118:Ophthalmology Therapeutics Market, Japan, Diseased Population (Millions), 2009-2016
Table 119:Ophthalmology Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2001-2009
Table 120: Ophthalmology Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2009-2016
Table 121:Ophthalmology Therapeutics Market, Japan, Diagnosed Population (Millions), 2001-2009
Table 122:Ophthalmology Therapeutics Market, Japan, Diagnosed Population (Millions), 2001-2016
Table 123:Ophthalmology Therapeutics Market, Japan, Prescription Population (Millions), 2001-2009
Table 124:Ophthalmology Therapeutics Market, Japan, Prescription Population (Millions), 2009-2016
Table 125:Ophthalmology Therapeutics Market, Pfizer, Pipeline Products, 2010
Table 126:Ophthalmology Therapeutics Market, Allergan, Pipeline Products, 2010
Table 127:Ophthalmology Therapeutics Market, Alcon, Pipeline Products, 2010
Table 128:Ophthalmology Therapeutics Market, Novartis, Pipeline Products, 2010
Table 129:Ophthalmology Therapeutics Market, Merck, Pipeline Products, 2010
Table 130:Ophthalmology Therapeutics Market, Global, Major M&A Deals, 2008-2009
Table 131:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs in the Preclinical and Discovery Stage, 2008-2010
Table 132:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs in Phase I, 2008-2010
Table 133:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs in Phase II, 2008-2010
Table 134:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs in Phase III, 2008-2010
Table 135:Ophthalmology Therapeutics Market, Global, Licensing Agreements for Drugs for Approved Products, 2008-2010

List of Figures:

Figure 1: Ophthalmology Therapeutics Market, Global, Sales Value ($bn), 2001-2016
Figure 2: Ophthalmology Therapeutics Market, Global, Annual Cost of Therapy ($), 2001-2016
Figure 3: Ophthalmology Therapeutics Market, Global, Treatment Usage Patterns, 2001-2016
Figure 4: Ophthalmology Therapeutics Market, Global, Diseased Population (millions), 2001-2016
Figure 5: Ophthalmology Therapeutics Market, Global, Treatment Seeking Population (millions), 2001-2016
Figure 6: Ophthalmology Therapeutics Market, Global, Diagnosed Population (millions), 2001-2016
Figure 7: Ophthalmology Therapeutics Market, Global, Prescription Population (millions), 2001-2016
Figure 8: Ophthalmology Therapeutics Market, Global, Sales of Generics Vs Branded Drugs ($bn), 2001-2016
Figure 9: Ophthalmology Therapeutics Market, Global, Market Share by Indication, 2009 and 2016
Figure 10: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Value ($bn), 2001-2016
Figure 11: Ophthalmology Therapeutics Market, Global, Glaucoma Sales Volume (Millions), 2001-2016
Figure 12: Ophthalmology Therapeutics Market, Global, Glaucoma Annual Cost of Therapy ($), 2001-2016
Figure 13: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Usage Patterns, 2001-2016
Figure 14: Ophthalmology Therapeutics Market, Global, Glaucoma Diseased Population, 2001-2016
Figure 15: Ophthalmology Therapeutics Market, Global, Glaucoma Treatment Seeking Population, 2001-2016
Figure 16: Ophthalmology Therapeutics Market, Global, Glaucoma Diagnosed Population, 2001-2016
Figure 17: Ophthalmology Therapeutics Market, Global, Glaucoma Prescription Population, 2001-2016
Figure 18: Ophthalmology Therapeutics Market, Global, Glaucoma Market by Geography, 2009 and 2016
Figure 19: Ophthalmology Therapeutics Market, Global, Glaucoma Revenue by Geography, 2001-2016
Figure 20: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Value ($bn), 2001-2016
Figure 21: Ophthalmology Therapeutics Market, Global, Macular Edema Sales Volume (million), 2001-2016
Figure 22: Ophthalmology Therapeutics Market, Global, Annual Cost of Macular Edema Treatment, 2001-2016
Figure 23: Ophthalmology Therapeutics Market, Global, Macular Edema Treatment Usage Patterns, 2001-2016
Figure 24: Ophthalmology Therapeutics Market, Global, Macular Edema Diseased Population, 2001-2016
Figure 25: Ophthalmology Therapeutics Market, Global, Macular Edema Treatment Seeking Population, 2001-2016
Figure 26: Ophthalmology Therapeutics Market, Global, Macular Edema Diagnosed Population, 2001-2016
Figure 27: Ophthalmology Therapeutics Market, Global, Macular Edema Prescription Population, 2001-2016
Figure 28: Ophthalmology Therapeutics Market, Global, Macular Edema Market by Geography, 2008 and 2015
Figure 29: Ophthalmology Therapeutics Market, Global, Macular Edema Revenue by Geography, 2001-2016
Figure 30: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Value ($m), 2001-2016
Figure 31: Ophthalmology Therapeutics Market, Global, Macular Degeneration Sales Volume (Thousands), 2001-2016
Figure 32: Ophthalmology Therapeutics Market, Global, Macular Degeneration Annual Cost of Therapy ($), 2001-2016
Figure 33: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Usage Patterns, 2001-2016
Figure 34: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diseased Population (Millions), 2001-2016
Figure 35: Ophthalmology Therapeutics Market, Global, Macular Degeneration Treatment Seeking Population (Millions), 2001-2019
Figure 36: Ophthalmology Therapeutics Market, Global, Macular Degeneration Diagnosed Population (Millions), 2001-2016
Figure 37: Ophthalmology Therapeutics Market, Global, Macular Degeneration Prescription Population (Millions), 2001-2016
Figure 38: Ophthalmology Therapeutics Market, Global, Macular Degeneration Market by Geography, 2009 and 2016
Figure 39: Ophthalmology Therapeutics Market, Global, Macular Degeneration Market, Revenue by Geography ($m), 2001-2016
Figure 40: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Value ($m), 2001-2016
Figure 41: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Sales Volume (Millions), 2009-2016
Figure 42: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Annual Cost of Therapy ($), 2001-2016
Figure 43: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Usage Patterns (Millions), 2001-2016
Figure 44: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diseased Population, 2001-2016
Figure 45: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Treatment Seeking Population (Millions), 2001-2016
Figure 46: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Diagnosed Population (Millions), 2001-2016
Figure 47: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Prescription Population (Million), 2001-2016
Figure 48: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Market by Geography, 2009 and 2016
Figure 49: Ophthalmology Therapeutics Market, Global, Allergic Conjunctivitis Market, Revenue by Geography ($m), 2001-2016
Figure 50: Ophthalmology Therapeutics Market, Global, Market Share by Geography, 2009 and 2016
Figure 51: Ophthalmology Therapeutics Market, Global, Sales Value by Geography ($ bn), 2001-2016
Figure 52: Ophthalmology Therapeutics Market, US, Sales Value ($ bn), 2001-2016
Figure 53: Ophthalmology Therapeutics Market, US, Annual Cost of Therapy ($), 2001-2016
Figure 54: Ophthalmology Therapeutics Market, US, Treatment Usage Patterns, 2001-2016
Figure 55: Ophthalmology Therapeutics Market, US, Diseased Population (Millions), 2001-2016
Figure 56: Ophthalmology Therapeutics Market, US, Treatment Seeking Population (Millions), 2001-2016
Figure 57: Ophthalmology Therapeutics Market, US, Diagnosed Population (Millions), 2001-2016
Figure 58: Ophthalmology Therapeutics Market, US, Prescription Population (Millions), 2001-2016
Figure 59: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Sales Value ($ bn), 2001-2016
Figure 60: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Therapy ($), 2001-2016
Figure 61: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Patterns, 2001-2016
Figure 62: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Diseased Population (Millions), 2001-2016
Figure 63: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Treatment Seeking Population (Millions), 2001-2016
Figure 64: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Diagnosed Population (Millions), 2001-2016
Figure 65: Ophthalmology Therapeutics Market, Top Five Countries in Europe, Prescription Population (Millions), 2001-2016
Figure 66: Ophthalmology Therapeutics Market, Japan, Sales Value ($ bn), 2001-2016
Figure 67: Ophthalmology Therapeutics Market, Japan, Annual Cost of Therapy ($), 2001-2016
Figure 68: Ophthalmology Therapeutics Market, Japan, Treatment Usage Patterns, 2001-2016
Figure 69: Ophthalmology Therapeutics Market, Japan, Diseased Population (Millions), 2001-2016
Figure 70: Ophthalmology Therapeutics Market, Japan, Treatment Seeking Population (Millions), 2001-2016
Figure 71: Ophthalmology Therapeutics Market, Japan, Diagnosed Population (Millions), 2001-2016
Figure 72: Ophthalmology Therapeutics Market, Japan, Prescription Population (Millions), 2001-2016
Figure 73: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Indication (%), May 2010
Figure 74: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase (%), May 2010
Figure 75: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase in Macular Degeneration Market (%), May 2010
Figure 76: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase in Glaucoma Market (%) May 2010
Figure 77: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase in Macular Edema Market (%), May 2010
Figure 78: Ophthalmology Therapeutics Market, Global, R&D Pipeline by Phase in Allergic Conjunctivitis Market (%), May 2010
Figure 79: Ophthalmology Therapeutics Market, Global, Market Share of Top Manufacturers (%), 2009
Figure 80: Ophthalmology Therapeutics Market, Global, Revenue of Top Six Players in Ophthalmology Market ($m), 2007-2010
Figure 81: Ophthalmology Therapeutics Market, Global, Competitive Analysis of Top Six Players in Diabetes Market, 2006-2008
Figure 82: Ophthalmology Therapeutics Market, Pfizer, Share of Key Ophthalmology Drugs Revenue, n = $50bn, 2009
Figure 83: Ophthalmology Therapeutics Market, Allergan, Share of Key Ophthalmology Drugs Revenue, n = $4.5bn, 2009
Figure 84: Ophthalmology Therapeutics Market, Alcon, Share of Key Ophthalmology Drugs Revenue, n = $6.5bn, 2009
Figure 85: Ophthalmology Therapeutics Market, Novartis, Share of Key Ophthalmology Drugs Revenue, n = $27.4bn, 2009
Figure 86: Ophthalmology Therapeutics Market, Merck, Share of Key Ophthalmology Drugs Revenue, n = $41.3bn, 2009
Figure 87: Ophthalmology Therapeutics Market, Roche, Share of Key Ophthalmology Drugs Revenue, n = $45.3bn, 2009
Figure 88:Research Methodology, 2010
Figure 89:Research Market Forecasting Model, 2010

FEATURED COMPANIES

  • Alcon, Inc.
  • Allergan, Inc.
  • Merck & Co Inc
  • Novartis AG
  • Pfizer
  • Roche
  • MORE

“The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key Markets”, provides in-depth analysis of the unmet needs, drivers and barriers that impact the global ophthalmology therapeutics market. The report analyzes the ophthalmology markets in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive profiling for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Ophthalmology Markets Like Glaucoma Face Generic Erosion While Macular Degeneration and Edema Experience Healthy Growth

The authors have found that the global ophthalmology market will grow at a moderate rate due to the impact of generic erosion in some markets such as glaucoma and allergic conjunctivitis.

Ophthalmology Therapeutics Market, Global, Market Share by Geography, 2009 and 2016

However, the unmet need in the macular degeneration and macular edema markets make the ophthalmology market attractive despite generic erosion. The attractiveness of the macular degeneration and macular edema markets is evident from the considerable amount of research and development activity for these indications. The major factor driving the growth of the market is the rising awareness about the importance of detecting ophthalmic diseases early, the availability of effective diagnostic tools and an increase in the prevalence of diabetes. The expiry of blockbuster drugs’ patents and increasing pressure from cheap off-label products in some markets will be the key restraints for the market.

The entry of generics will cause glaucoma’s market share to shrink. The macular degeneration and macular edema markets will eat into glaucoma’s share. The share of the market generated by allergic conjunctivitis therapies, which includes a considerable number of generics, will remain the same in 2016. Due to the extensive presence of generics in the market, allergic conjunctivitis companies will take steps to improve the revenue potential of their drugs. The Rx to OTC switch is one of the strategies that can be leveraged at the right time to increase revenue potential. In addition, strategies such as branded generics will be increasingly used in the ophthalmology market.

- Pfizer
- Allergan, Inc.
- Alcon, Inc.
- Novartis AG
- Merck & Co Inc
- Roche

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos